Using a systems genetics approach, a new study identifies genetic variants and proteins associated with plasma and hepatic lipid abundance and hepatic lipotoxicity.
References
Moore, J. B. Proc. Nutr. Soc. https://doi.org/10.1017/S0029665119000570 (2019).
Parker, B. L. et al. Nature 567, 187–193 (2019).
Spanos, C. et al. Proteome Sci. 16, 4 (2018).
Xue, M. et al. Diabetes 65, 2282–2294 (2016).
Kaneko, T. et al. Cell 137, 914–925 (2009).
Baumeier, C. et al. Biochim. Biophys. Acta 1851, 566–576 (2015).
Stanojevic, V., Yao, K. M. & Thomas, M. K. Mol. Cell. Endocrinol. 237, 67–74 (2005).
Mardinoglu, A. et al. Nat. Commun. 5, 3083 (2014).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Moore, J.B., Thorne, J.L. Predicting and reducing hepatic lipotoxicity in non-alcoholic fatty liver disease. Lab Anim 48, 143–144 (2019). https://doi.org/10.1038/s41684-019-0291-0
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41684-019-0291-0
- Springer Nature America, Inc.